BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 194 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,463 | -12.5% | 33,540 | -13.0% | 0.02% | -13.6% |
| Q2 2023 | $271,322 | -18.5% | 38,540 | -3.5% | 0.02% | -21.4% |
| Q1 2023 | $333,100 | +72788.4% | 39,940 | +0.4% | 0.03% | -33.3% |
| Q4 2022 | $457 | -99.9% | 39,800 | +1.9% | 0.04% | -17.6% |
| Q3 2022 | $492,000 | +4.7% | 39,050 | -12.1% | 0.05% | +21.4% |
| Q2 2022 | $470,000 | -26.8% | 44,450 | +12.5% | 0.04% | -19.2% |
| Q1 2022 | $642,000 | +2.7% | 39,500 | -12.5% | 0.05% | +2.0% |
| Q4 2021 | $625,000 | +4.9% | 45,125 | +8.8% | 0.05% | -16.4% |
| Q3 2021 | $596,000 | +44.0% | 41,475 | +58.3% | 0.06% | +45.2% |
| Q2 2021 | $414,000 | +123.8% | 26,200 | +44.0% | 0.04% | +121.1% |
| Q1 2021 | $185,000 | – | 18,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |